Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Latest Information Update: 30 Jan 2025
At a glance
- Drugs Tralokinumab (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Acronyms PROTECT
Most Recent Events
- 12 Jan 2024 According to a LEO Pharma media release, the company will present interim result at the upcoming Winter Clinical and Maui Derm conferences this month. The 2024 Winter Clinical Conference will take place Jan. 12-17 in Honolulu, Hawaii, while Maui Derm is being held from Jan. 22-26 in Maui, Hawaii.
- 12 Jul 2023 New trial record